Search

Author/Creator Java, James J. Subject 618

1. Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer. Issue 8 (August 2015)

Authors:
Tewari, Devansu; Java, James J.; Salani, Ritu; Armstrong, Deborah K.; Markman, Maurie; Herzog, Thomas; Monk, Bradley J.; Chan, John K.
Journal:
Obstetrical & gynecological survey
Issue:
Volume 70:Issue 8(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma. Issue 2 (February 2019)

Authors:
Rose, Peter G.; Java, James J.; Salani, Ritu; Geller, Melissa A.; Secord, Angeles Alvarez; Tewari, Krishnansu S.; Bender, David P.; Mutch, David G.; Friedlander, Michael L.; Van Le, Linda; Method, Michael W.; Hamilton, Chad A.; Lee, Roger B.; Wenham, Robert M.; Guntupalli, Saketh R.; Markman, Mau...
Journal:
Obstetrics and gynecology
Issue:
Volume 133:Issue 2(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Risk Factors for Readmission in Patients With Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Who Are Receiving Front-line Chemotherapy on a Clinical Trial (GOG 218): An NRG Oncology/Gynecologic Oncology Group Study (ADS-1236). Issue 1 (January 2016)

Authors:
Duska, Linda R.; Java, James J.; Cohn, David E.; Burger, Robert A.
Journal:
Obstetrical & gynecological survey
Issue:
Volume 71:Issue 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗